Tech Company Financing Transactions
SereNeuro Therapeutics Funding Round
Private investors participated in a Seed venture round for SereNeuro Therapeutics. The round was announced on 10/6/2026.
Transaction Overview
Company Name
Announced On
10/6/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead program, SN101, toward Investigational New Drug (IND)-enabling activities and support its second program, SN102.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1812 Ashland Avenue 100
Baltimore, MD 21205
USA
Baltimore, MD 21205
USA
Phone
Undisclosed
Website
Email Address
Overview
SereNeuro Therapeutics is a preclinical biotechnology company dedicated to developing non-opioid therapies for chronic pain. The company's programs specifically target chronic osteoarthritis joint pain and neuropathic pain, aiming to challenge traditional pain management logic through distinct, non-opioid mechanisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Saragnese
Chief Scientific Officer
Laura Richman
Chief Technical Officer
Oliver Kraemer
Co-Founder
Xinzhong Dong
Co-Founder
Gabsang Lee
Co-Founder
Zhuolun Wang
Browse more venture capital transactions:
Prev: 10/6/2026: Weed Man venture capital transaction
Next: 10/6/2026: KymaThera venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs